Case and Research Letter
Relapse of morphea during Nivolumab therapy for lung adenocarcinoma
Recaída de morfea durante tratamiento con Nivolumab en adenocarcinoma de pulmón
A. Alegre-Sánchez
, P. Fonda-Pascual, D. Saceda-Corralo, E. de las Heras-Alonso
Autor para correspondencia
Dermatology Service, Ramon y Cajal Hospital, Madrid, Spain
Leído
5628
Vecesse ha leído el artículo
2088
Total PDF
3540
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 32 | 6 | 38 |
| 2025 5 | 135 | 41 | 176 |
| 2025 4 | 139 | 22 | 161 |
| 2025 3 | 124 | 13 | 137 |
| 2025 2 | 131 | 31 | 162 |
| 2025 1 | 102 | 25 | 127 |
| 2024 12 | 82 | 28 | 110 |
| 2024 11 | 86 | 44 | 130 |
| 2024 10 | 69 | 40 | 109 |
| 2024 9 | 67 | 20 | 87 |
| 2024 8 | 73 | 49 | 122 |
| 2024 7 | 67 | 27 | 94 |
| 2024 6 | 69 | 29 | 98 |
| 2024 5 | 58 | 30 | 88 |
| 2024 4 | 68 | 25 | 93 |
| 2024 3 | 69 | 26 | 95 |
| 2024 2 | 56 | 28 | 84 |
| 2024 1 | 51 | 33 | 84 |
| 2023 12 | 54 | 16 | 70 |
| 2023 11 | 72 | 17 | 89 |
| 2023 10 | 65 | 22 | 87 |
| 2023 9 | 44 | 33 | 77 |
| 2023 8 | 34 | 14 | 48 |
| 2023 7 | 30 | 31 | 61 |
| 2023 6 | 34 | 22 | 56 |
| 2023 5 | 40 | 30 | 70 |
| 2023 4 | 35 | 15 | 50 |
| 2023 3 | 40 | 22 | 62 |
| 2023 2 | 39 | 22 | 61 |
| 2022 1 | 42 | 38 | 80 |
| 2022 12 | 52 | 40 | 92 |
| 2022 11 | 22 | 29 | 51 |
| 2022 10 | 22 | 18 | 40 |
| 2022 9 | 22 | 32 | 54 |
| 2022 8 | 51 | 23 | 74 |
| 2022 7 | 38 | 34 | 72 |
| 2022 6 | 32 | 29 | 61 |
| 2022 5 | 26 | 24 | 50 |
| 2022 4 | 26 | 36 | 62 |
| 2022 3 | 43 | 42 | 85 |
| 2022 2 | 30 | 20 | 50 |
| 2021 1 | 49 | 35 | 84 |
| 2021 12 | 31 | 30 | 61 |
| 2021 11 | 25 | 46 | 71 |
| 2021 10 | 45 | 48 | 93 |
| 2021 9 | 27 | 49 | 76 |
| 2021 8 | 31 | 30 | 61 |
| 2021 7 | 30 | 29 | 59 |
| 2021 6 | 27 | 30 | 57 |
| 2021 5 | 40 | 51 | 91 |
| 2021 4 | 56 | 79 | 135 |
| 2021 3 | 69 | 41 | 110 |
| 2021 2 | 40 | 37 | 77 |
| 2020 1 | 32 | 32 | 64 |
| 2020 12 | 40 | 34 | 74 |
| 2020 11 | 25 | 23 | 48 |
| 2020 10 | 28 | 24 | 52 |
| 2020 9 | 32 | 18 | 50 |
| 2020 8 | 28 | 36 | 64 |
| 2020 7 | 29 | 24 | 53 |
| 2020 6 | 30 | 32 | 62 |
| 2020 5 | 19 | 12 | 31 |
| 2020 4 | 26 | 18 | 44 |
| 2020 3 | 25 | 16 | 41 |
| 2020 2 | 8 | 0 | 8 |
| 2020 1 | 4 | 0 | 4 |
| 2019 12 | 8 | 0 | 8 |
| 2019 11 | 2 | 0 | 2 |
| 2019 9 | 11 | 0 | 11 |
| 2019 8 | 7 | 0 | 7 |
| 2019 7 | 4 | 0 | 4 |
| 2019 6 | 4 | 0 | 4 |
| 2019 5 | 4 | 1 | 5 |
| 2019 4 | 2 | 3 | 5 |
| 2019 3 | 1 | 2 | 3 |
| 2019 2 | 6 | 0 | 6 |
| 2018 12 | 5 | 2 | 7 |
| 2018 11 | 4 | 0 | 4 |
| 2018 10 | 5 | 0 | 5 |
| 2018 9 | 2 | 0 | 2 |
| 2018 2 | 14 | 6 | 20 |
| 2018 1 | 20 | 8 | 28 |
| 2017 12 | 28 | 13 | 41 |
| 2017 11 | 14 | 8 | 22 |
| 2017 10 | 10 | 7 | 17 |
| 2017 9 | 18 | 7 | 25 |
| 2017 8 | 19 | 11 | 30 |
| 2017 7 | 14 | 6 | 20 |
| 2017 6 | 22 | 15 | 37 |
| 2017 5 | 17 | 11 | 28 |
| 2017 4 | 25 | 13 | 38 |
| 2017 3 | 22 | 14 | 36 |
| 2017 2 | 33 | 23 | 56 |
| 2016 1 | 47 | 35 | 82 |
| 2016 12 | 5 | 3 | 8 |
Mostrar todo
